Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma-Reference-Cited by-同舟云学术

Integrative Analysis Reveals an Outcome-Associated and Targetable Pattern of p53 and Cell Cycle Deregulation in Diffuse Large B Cell Lymphoma

Published:2012-09 Issue:3 Volume:22 Page:359-372
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Monti Stefano,Chapuy Bjoern,Takeyama Kunihiko,Rodig Scott J.,Hao Yansheng,Yeda Kelly T.,Inguilizian Haig,Mermel Craig,Currie Treeve,Dogan Ahmet,Kutok Jeffery L.,Beroukhim Rameen,Neuberg Donna,Habermann Thomas M.,Getz Gad,Kung Andrew L.,Golub Todd R.,Shipp Margaret A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference66 articles.

1. The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence;Agger;Genes Dev.,2009

2. Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction;Bea;Blood,2005

3. Loss of the p53/p63 regulated desmosomal protein Perp promotes tumorigenesis;Beaudry;PLoS Genet.,2010

4. A stapled p53 helix overcomes HDMX-mediated suppression of p53;Bernal;Cancer Cell,2010

5. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma;Beroukhim;Proc. Natl. Acad. Sci. USA,2007

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic classification of diffuse large B-cell lymphoma identifies a high-risk activated B-cell-like subpopulation with targetable MYC dysregulation;Nature Communications;2024-08-08

2. Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged organ-tropism;2024-07-17

3. Genomic landscape and distinct molecular subtypes of primary testicular lymphoma;Journal of Translational Medicine;2024-05-01

4. NGS-determined molecular markers and disease burden metrics from ctDNA correlate with PFS in previously untreated DLBCL;Leukemia & Lymphoma;2024-02-09

5. Progress in deciphering the role of p53 in diffuse large B-cell lymphoma: mechanisms and therapeutic targets;American Journal of Cancer Research;2024